Xtalks is Connecting Industry

Celebrating 20 Years of delivering webinars to FDA & EMA regulated industries.

Join free for access to live and recorded webinars, news, videos, job postings and more.

Take a Site Tour

Get a 1 min 30 second tutorial that outlines our new website

Communicate Your Area of Expertise

Learn why you should be hosting a webinar on Xtalks.com

Life Science Webinars

Register for an upcoming webinar or explore our large library of on-demand life science webinars

Medical Device Webinars

Register for an upcoming webinar or explore our large library of on-demand medical device webinars

Food Industry Webinars

Register for an upcoming webinar or explore our large library of on-demand food industry webinars

Xtalks is Connecting Industry

Celebrating 20 Years of delivering webinars to FDA & EMA regulated industries.

Join free for access to live and recorded webinars, news, videos, job postings and more.

Take a Site Tour

Get a 1 min 30 second tutorial that outlines our new website

Communicate Your Area of Expertise

Learn why you should be hosting a webinar on Xtalks.com

Life Science Webinars

Register for an upcoming webinar or explore our large library of on-demand life science webinars

Medical Device Webinars

Register for an upcoming webinar or explore our large library of on-demand medical device webinars

Food Industry Webinars

Register for an upcoming webinar or explore our large library of on-demand food industry webinars

Upcoming Webinars

View All
March 28, 2023

Rare Disease Week 2023: Exploring Accessibility in Rare Disease Clinical Research (4-Day Webinar Series)
Rare Disease Week 2023: Exploring Accessibility in Rare Disease Clinical Research (4-Day Webinar Series)
March 28, 2023

Behavioral Science in Clinical Trials: Unleashing the Benefits and Eliminating Bias
Behavioral Science in Clinical Trials: Unleashing the Benefits and Eliminating Bias
March 28, 2023

rAAV Manufacturing — Enzymatic DNA for Achieving a Robust & High-Quality DNA Supply
rAAV Manufacturing — Enzymatic DNA for Achieving a Robust & High-Quality DNA Supply
March 29, 2023

Challenges in Assessing Long-Term Effects of Covid and Covid Vaccines
Challenges in Assessing Long-Term Effects of Covid and Covid Vaccines
March 30, 2023

Ocular Toxicity Studies: Technical Considerations and Pathology Reporting Expectations
Ocular Toxicity Studies: Technical Considerations and Pathology Reporting Expectations
March 30, 2023

New Options for TQT Waivers from First-in-Human and Oncology Phase I Studies
New Options for TQT Waivers from First-in-Human and Oncology Phase I Studies
March 31, 2023

Clinical Supply Chain Strategies for Building Resilience
Clinical Supply Chain Strategies for Building Resilience
March 31, 2023

AAV Gene Therapy — Optimizing Scale-Up to 2,000 L in Upstream Processing
AAV Gene Therapy — Optimizing Scale-Up to 2,000 L in Upstream Processing
March 28, 2023

Rare Disease Week 2023: Exploring Accessibility in Rare Disease Clinical Research (4-Day Webinar Series)
Rare Disease Week 2023: Exploring Accessibility in Rare Disease Clinical Research (4-Day Webinar Series)
March 28, 2023

Behavioral Science in Clinical Trials: Unleashing the Benefits and Eliminating Bias
Behavioral Science in Clinical Trials: Unleashing the Benefits and Eliminating Bias
March 28, 2023

rAAV Manufacturing — Enzymatic DNA for Achieving a Robust & High-Quality DNA Supply
rAAV Manufacturing — Enzymatic DNA for Achieving a Robust & High-Quality DNA Supply
March 29, 2023

Challenges in Assessing Long-Term Effects of Covid and Covid Vaccines
Challenges in Assessing Long-Term Effects of Covid and Covid Vaccines
March 30, 2023

Ocular Toxicity Studies: Technical Considerations and Pathology Reporting Expectations
Ocular Toxicity Studies: Technical Considerations and Pathology Reporting Expectations
March 30, 2023

New Options for TQT Waivers from First-in-Human and Oncology Phase I Studies
New Options for TQT Waivers from First-in-Human and Oncology Phase I Studies
March 31, 2023

Clinical Supply Chain Strategies for Building Resilience
Clinical Supply Chain Strategies for Building Resilience
March 31, 2023

AAV Gene Therapy — Optimizing Scale-Up to 2,000 L in Upstream Processing
AAV Gene Therapy — Optimizing Scale-Up to 2,000 L in Upstream Processing

On-Demand Webinars

View All
March 23, 2023

Biosimilarity and Sameness Testing: Analytical Strategies to Fulfill FDA Submission Requirements
Biosimilarity and Sameness Testing: Analytical Strategies to Fulfill FDA Submission Requirements
March 23, 2023

CAR T-Cell Therapies: Extending Hope with Broadened Access
CAR T-Cell Therapies: Extending Hope with Broadened Access
March 22, 2023

Approaches to Developing an AI-based Pharmacovigilance System – Automation is Changing the Way Pharma Manages Pharmacovigilance
Approaches to Developing an AI-based Pharmacovigilance System – Automation is Changing the Way Pharma Manages Pharmacovigilance
March 22, 2023

Improving Data Quality and Reducing Site/Patient Burden in Remote Rare Disease Trials
Improving Data Quality and Reducing Site/Patient Burden in Remote Rare Disease Trials
March 23, 2023

Biosimilarity and Sameness Testing: Analytical Strategies to Fulfill FDA Submission Requirements
Biosimilarity and Sameness Testing: Analytical Strategies to Fulfill FDA Submission Requirements
March 23, 2023

CAR T-Cell Therapies: Extending Hope with Broadened Access
CAR T-Cell Therapies: Extending Hope with Broadened Access
March 22, 2023

Approaches to Developing an AI-based Pharmacovigilance System – Automation is Changing the Way Pharma Manages Pharmacovigilance
Approaches to Developing an AI-based Pharmacovigilance System – Automation is Changing the Way Pharma Manages Pharmacovigilance
March 22, 2023

Improving Data Quality and Reducing Site/Patient Burden in Remote Rare Disease Trials
Improving Data Quality and Reducing Site/Patient Burden in Remote Rare Disease Trials

Featured Editorial

Vitals

Your source for industry focused blog articles, news, videos, polls & quizzes

View All

Rezzayo (Rezafungin) Becomes First New Treatment Option for Candidemia and Invasive Candidiasis in Over a Decade
Rezzayo (Rezafungin) Becomes First New Treatment Option for Candidemia and Invasive Candidiasis in Over a Decade
News

New FDA Budget Downplays Food Safety, Again
New FDA Budget Downplays Food Safety, Again
News

Incyte’s Immunotherapy Zynyz Wins Approval for Advanced Skin Cancer After Previous Setback
Incyte’s Immunotherapy Zynyz Wins Approval for Advanced Skin Cancer After Previous Setback
Pharmaceutical News

Rezzayo (Rezafungin) Becomes First New Treatment Option for Candidemia and Invasive Candidiasis in Over a Decade
Rezzayo (Rezafungin) Becomes First New Treatment Option for Candidemia and Invasive Candidiasis in Over a Decade
News

New FDA Budget Downplays Food Safety, Again
New FDA Budget Downplays Food Safety, Again
News

Incyte’s Immunotherapy Zynyz Wins Approval for Advanced Skin Cancer After Previous Setback
Incyte’s Immunotherapy Zynyz Wins Approval for Advanced Skin Cancer After Previous Setback
Pharmaceutical News

Vitals

Your source for industry focused blog articles, news, videos, polls & quizzes

View All

Industry Jobs

Search Jobs

Canada

Regional Manager – US Patient...

Our Patient Services team provides exceptional customer service on all l...

Closing: April 26, 2023

United States

Case Manager

We are continuing to build out our US Patient Services team to provide e...

Closing: April 26, 2023

Cambridge, United States

VP, Head of US Medical...

Alnylam (Nasdaq: ALNY) is delivering on a bold vision to turn scientific...

Closing: April 26, 2023

Cambridge, United States

Postdoctoral Research Fellow, Pharmacometrics

Alnylam is the world’s leading RNA interference (RNAi) company. Founded ...

Closing: April 26, 2023

Canada

Regional Manager – US Patient...

Our Patient Services team provides exceptional customer service on all l...

Closing: April 26, 2023

United States

Case Manager

We are continuing to build out our US Patient Services team to provide e...

Closing: April 26, 2023

Cambridge, United States

VP, Head of US Medical...

Alnylam (Nasdaq: ALNY) is delivering on a bold vision to turn scientific...

Closing: April 26, 2023

Cambridge, United States

Postdoctoral Research Fellow, Pharmacometrics

Alnylam is the world’s leading RNA interference (RNAi) company. Founded ...

Closing: April 26, 2023

Xtalks is Connecting Industry

Xtalks is Connecting Industry

Gain knowledge and stay up-to-date with the latest industry developments. Join your community to view webinars, earn points, share discussions, articles, and more.

Host A Webinar

Host A Webinar

Hiring?

Hiring?